Cargando…
A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies
Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction pow...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991680/ https://www.ncbi.nlm.nih.gov/pubmed/35394257 http://dx.doi.org/10.1007/s11538-022-01012-8 |
_version_ | 1784683621263605760 |
---|---|
author | Wang, Xiunan Wang, Hao Ramazi, Pouria Nah, Kyeongah Lewis, Mark |
author_facet | Wang, Xiunan Wang, Hao Ramazi, Pouria Nah, Kyeongah Lewis, Mark |
author_sort | Wang, Xiunan |
collection | PubMed |
description | Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction power. Typically, a hypothesis is made on the form of the transmission rate with respect to time. Yet the real form is too complex to be mechanistically modeled due to the unknown dynamics of many influential factors. We tackle this problem by using a hypothesis-free machine-learning algorithm to estimate the transmission rate from data on non-pharmaceutical policies, and in turn forecast the confirmed cases using a mechanistic disease model. More specifically, we build a hybrid model consisting of a mechanistic ordinary differential equation (ODE) model and a gradient boosting model (GBM). To calibrate the parameters, we develop an “inverse method” that obtains the transmission rate inversely from the other variables in the ODE model and then feed it into the GBM to connect with the policy data. The resulting model forecasted the number of daily confirmed cases up to 35 days in the future in the USA with an averaged mean absolute percentage error of 27%. It can identify the most informative predictive variables, which can be helpful in designing improved forecasters as well as informing policymakers. |
format | Online Article Text |
id | pubmed-8991680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-89916802022-04-11 A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies Wang, Xiunan Wang, Hao Ramazi, Pouria Nah, Kyeongah Lewis, Mark Bull Math Biol Original Article Accurate prediction of the number of daily or weekly confirmed cases of COVID-19 is critical to the control of the pandemic. Existing mechanistic models nicely capture the disease dynamics. However, to forecast the future, they require the transmission rate to be known, limiting their prediction power. Typically, a hypothesis is made on the form of the transmission rate with respect to time. Yet the real form is too complex to be mechanistically modeled due to the unknown dynamics of many influential factors. We tackle this problem by using a hypothesis-free machine-learning algorithm to estimate the transmission rate from data on non-pharmaceutical policies, and in turn forecast the confirmed cases using a mechanistic disease model. More specifically, we build a hybrid model consisting of a mechanistic ordinary differential equation (ODE) model and a gradient boosting model (GBM). To calibrate the parameters, we develop an “inverse method” that obtains the transmission rate inversely from the other variables in the ODE model and then feed it into the GBM to connect with the policy data. The resulting model forecasted the number of daily confirmed cases up to 35 days in the future in the USA with an averaged mean absolute percentage error of 27%. It can identify the most informative predictive variables, which can be helpful in designing improved forecasters as well as informing policymakers. Springer US 2022-04-08 2022 /pmc/articles/PMC8991680/ /pubmed/35394257 http://dx.doi.org/10.1007/s11538-022-01012-8 Text en © The Author(s), under exclusive licence to Society for Mathematical Biology 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Wang, Xiunan Wang, Hao Ramazi, Pouria Nah, Kyeongah Lewis, Mark A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies |
title | A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies |
title_full | A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies |
title_fullStr | A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies |
title_full_unstemmed | A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies |
title_short | A Hypothesis-Free Bridging of Disease Dynamics and Non-pharmaceutical Policies |
title_sort | hypothesis-free bridging of disease dynamics and non-pharmaceutical policies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991680/ https://www.ncbi.nlm.nih.gov/pubmed/35394257 http://dx.doi.org/10.1007/s11538-022-01012-8 |
work_keys_str_mv | AT wangxiunan ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT wanghao ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT ramazipouria ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT nahkyeongah ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT lewismark ahypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT wangxiunan hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT wanghao hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT ramazipouria hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT nahkyeongah hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies AT lewismark hypothesisfreebridgingofdiseasedynamicsandnonpharmaceuticalpolicies |